Advanced BioMedical Technologies, Inc. Diluted Shares Outstanding (Weighted Average)
Advanced BioMedical Technologies, Inc. reported Diluted Shares Outstanding (Weighted Average) of 70.46 million shares for the 3-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-07-31 was 70.46M shares, a 0.36% increase year-over-year.
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-04-30 was 70.46M shares, a 0.52% increase year-over-year.
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-01-31 was 70.30M shares, a 0.61% increase year-over-year.
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2020-10-31 was 70.23M shares, a 0.86% increase year-over-year.
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for fiscal 2020 was 70.10M shares, a 0.69% increase from fiscal 2019.
- Advanced BioMedical Technologies, Inc. weighted average number of shares outstanding, diluted for fiscal 2019 was 69.63M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2021-07-31 | 70.46M shares 10-Q · filed 2021-09-13 | 70.46M shares derived: average of 2 quarters · filed 2021-09-13 | 70.46M shares 10-Q · filed 2021-09-13 | 70.36M shares derived: average of 4 quarters · filed 2021-09-13 |
| 2021-04-30 | 70.46M shares 10-Q · filed 2021-06-21 | 70.46M shares 10-Q · filed 2021-06-21 | 70.33M shares derived: average of 3 quarters · filed 2021-06-21 | 70.30M shares derived: average of 4 quarters · filed 2021-09-13 |
| 2021-01-31 | 70.30M shares 10-Q · filed 2021-03-22 | 70.26M shares derived: average of 2 quarters · filed 2021-03-22 | 70.25M shares derived: average of 3 quarters · filed 2021-09-13 | 70.21M shares derived: average of 4 quarters · filed 2021-09-13 |
| 2020-10-31 | 70.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | 70.22M shares derived: average of 2 quarters · filed 2021-09-13 | 70.18M shares derived: average of 3 quarters · filed 2021-09-13 | 70.10M shares 10-K · filed 2021-01-29 |
| 2020-07-31 | 70.21M shares 10-Q · filed 2021-09-13 | 70.16M shares derived: average of 2 quarters · filed 2021-09-13 | 70.06M shares 10-Q · filed 2021-09-13 | 69.95M shares derived: average of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | 70.10M shares 10-Q · filed 2021-06-21 | 69.99M shares 10-Q · filed 2021-06-21 | 69.87M shares derived: average of 3 quarters · filed 2021-06-21 | 69.81M shares derived: average of 4 quarters · filed 2021-06-21 |
| 2020-01-31 | 69.87M shares 10-Q · filed 2021-03-22 | 69.75M shares derived: average of 2 quarters · filed 2021-03-22 | 69.71M shares derived: average of 3 quarters · filed 2021-03-22 | 69.69M shares derived: average of 4 quarters · filed 2021-03-22 |
| 2019-10-31 | 69.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | 69.63M shares derived: average of 2 quarters · filed 2021-01-29 | 69.63M shares derived: average of 3 quarters · filed 2021-01-29 | 69.63M shares 10-K · filed 2021-01-29 |
| 2019-07-31 | 69.62M shares 10-Q · filed 2020-09-21 | 69.62M shares derived: average of 2 quarters · filed 2020-09-21 | 69.62M shares 10-Q · filed 2020-09-21 | |
| 2019-04-30 | 69.62M shares 10-Q · filed 2020-06-22 | 69.62M shares 10-Q · filed 2020-06-22 |